Descriptive profile of surgically-confirmed adult central nervous system tumors in Puerto Rico

Puerto Rico Health Sciences Journal

Volumn 28, Issue 4, 2009, Pages 317-328

  Murray, Gisela ^a   Jiménez, Lincoln ^a   Báez, Frankie ^a   Colón Castillo, Lilliam E ^b   Brau, Ricardo H ^a  

^a UNIVERSITY OF PUERTO RICO   (Puerto Rico)

^b UNIVERSITY OF PUERTO RICO SCHOOL OF MEDICINE   (Puerto Rico)

Author keywords

CNS tumors; Neuro oncology; Neurosurgery; Puerto rico; Tumor incidence

Indexed keywords

ADULT; AGED; ARTICLE; CENTRAL NERVOUS SYSTEM TUMOR; FEMALE; HUMAN; MALE; MIDDLE AGED; PATHOLOGY; PUERTO RICO; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; CENTRAL NERVOUS SYSTEM NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; PUERTO RICO; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 72849143882     PISSN: 07380658     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. CBTRUS: Central Brain Tumor Registry of the United States (years 1998-2002), in, 2005-2006. Available at: URL: http://www.cbtrus.org/.
2. Davis FG, McCarthy B: Epidemiology of brain tumors: incidence, survival and risks factors, in McLendon RE, Bigner DD, Rosenblum MK (eds): Russell & Rubinstein's Pathology of Tumors of the Nervous System ed 7. London: Hodder Arnold Publication; 2006: p. 11-35.
3. Davis FG, McCarthy BJ, Berger MS. Centralized databases available for describing primary brain tumor incidence, survival, and treatment: Central Brain Tumor Registry of the United States; Surveillance, Epidemiology, and End Results; and National Cancer Data Base. Neuro Oncol 1999;1:205-211.
4. Demuth T, Berens ME. Molecular mechanisms of glioma cell migration and invasion. J Neurooncol 2004;70:217-228.
5. McCarthy BJ, Surawicz T, Bruner JM, Kruchko C, Davis F. Consensus Conference on Brain Tumor Definition for registration. November 10, 2000. Neuro Oncol 2002;4:134-145.
6. Propp JM, McCarthy BJ, Davis FG, Preston-Martin S. Descriptive epidemiology of vestibular schwannomas. Neuro Oncol 2006;8: 1-11.
7. Surawicz TS, McCarthy BJ, Kupelian V, Jukich PJ, Bruner JM, Davis FG. Descriptive epidemiology of primary brain and CNS tumors: results from the Central Brain Tumor Registry of the United States, 1990-1994. Neuro Oncol 1999;1:14-25.
8. Kaneko S, Nomura K, Yoshimura T, Yamaguchi N. Trend of brain tumor incidence by histological subtypes in Japan: estimation from the Brain Tumor Registry of Japan, 1973-1993. J Neurooncol 2002;60:61-69.
9. Lonn S, Klaeboe L, Hall P, Mathiesen T, Auvinen A, Christensen HC, et al. Incidence trends of adult primary intracerebral tumors in four Nordic countries. Int J Cancer 2004;108:450-455.
10. Pobereskin LH, Chadduck JB. Incidence of brain tumours in two English counties: a population based study. J Neurol Neurosurg Psychiatry 2000;69:464-471.
11. Shugg D, Allen BJ, Blizzard L, Dwyer T, Roder D. Brain cancer incidence, mortality and case survival: observations from two Australian cancer registries. Int J Cancer 1994;59:765-770.
12. Drut R. Incidence of malignant tumors in childhood in La Plata (1977-1981) and its comparison with other countries. Medicina (B Aires) 1984;44:23-28.
13. Fajardo-Gutiérrez A, Juarez-Ocana S, González-Miranda G, Palma-Padilla V, Carreón-Cruz R, Ortega-Álvarez MC, et al. Incidence of cancer in children residing in ten jurisdictions of the Mexican Republic: importance of the Cancer registry (a population-based study). BMC Cancer 2007;7:68.
14. Olivares L, Alter M, Márquez L, Cisneros L, Sánchez C. Epidemiology of primary cerebral tumors in Mexico. Study of the population of the Instituto de la Salud del Seguro Social de los Trabajadores del Estado in the Distrito Federal. Salud Pública Mex 1971; 13:305-312.
15. Pérez-Perdomo RV, Rodríguez-Figueroa L. Characteristics of cancer patients under age 20 at a population-based registry, Puerto Rico, 1980-1991. P R Health Sci J 2000;19:123-129.
16. Puerto: Puerto Rico Central Cancer Registry, Preliminary Data 2002-2003, Puerto Rico Department of Health, in, May, 2007.
17. USA USCB, Division P: Annual Estimates of the Population for the United States, Regions, States, and Puerto Rico: April 1, 2000 to July 1, 2007 (NST-EST2007-01). Available at: URL: http://www.census.gov/popest/states/NST-ann-est.html.
18. Buckner JC, Brown PD, O'Neill BP, et al. Central nervous system tumors. Mayo Clin Proc 2007;82:1271-1286.
19. Lacroix M, Abi-Said D, Fourney DR, et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 2001;95:190-198.
20. Sills AK. Current treatment approaches to surgery for brain metastases. Neurosurgery 2005;57:S24-32.
21. McCormack BM, Miller DC, Budzilovich GN, et al. Treatment and survival of low-grade astrocytoma in adults--1977-1988. Neurosurgery 1992;31:636-642.
22. Samadani U, Stein S, Moonis G, et al. Stereotactic biopsy of brain stem masses: Decision analysis and literature review. Surg Neurol 2006;66:484-491.
23. Rabadan AT, Hernández D, Eleta M, et al. Factors related to surgical complications and their impact on the functional status in 236 open surgeries for malignant tumors in a Latino-American hospital. Surg Neurol 2007;68:412-420.
24. Bondy M, Ligon BL. Epidemiology and etiology of intracranial meningiomas: a review. J Neurooncol 1996;29:197-205.
25. Lim M, Harsh GR: Neuro-Oncology: an overview, in Rengachary SS, Ellenbogen RG (eds): Principles of Neurosurgery, ed 2. London; Elsevier Mosby, 2005: p. 429-441.
26. Chang L, Heitkemper MM. Gender differences in irritable bowel syndrome. Gastroenterology 2002;123:1686-1701.
27. Gold LD, Krumholz HM. Gender differences in treatment of heart failure and acute myocardial infarction: a question of quality or epidemiology? Cardiol Rev 2006;14:180-186.
28. Rosenfeld AG, Lindauer A, Darney BG. Understanding treatment-seeking delay in women with acute myocardial infarction: descriptions of decision-making patterns. Am J Crit Care 2005;14: 285-293.
29. Claus EB, Black PM. Survival rates and patterns of care for patients diagnosed with supratentorial low-grade gliomas: data from the SEER program, 1973-2001. Cancer 2006;106:1358-1363.
30. Hofmann MA, Coll SH, Kuchler I, et al. Prognostic factors and impact of treatment in melanoma brain metastases: better prognosis for women? Dermatology 2007;215:10-16.
31. Keles GE, Anderson B, Berger MS. The effect of extent of resection on time to tumor progression and survival in patients with glioblastoma multiforme of the cerebral hemisphere. Surg Neurol 1999;52:371-379.
32. Larjavaara S, Mantyla R, Salminen T, et al. Incidence of gliomas by anatomic location. Neuro Oncol 2007;9:319-325.
33. Russell SM, Elliott R, Forshaw D, et al. Resection of parietal lobe gliomas: incidence and evolution of neurological deficits in 28 consecutive patients correlated to the location and morphological characteristics of the tumor. J Neurosurg 2005;103:1010-1017.
34. Sloan AE, Abdolvahavi R, Hlatky R: Gliomas, in Rengachary SS, Ellenbogen RG (eds); Principles of Neurosurgery, ed 2. London; Elsevier Mosby, 2005: p. 451-467.
35. DeMonte F, Al-Mefty O: Meningiomas, in kaye AH, Edward R Laws J (eds): Brain Tumors. New York; Churchill Livingstone, 1995: p. 675-679.
36. Caroli E, Orlando ER, Mastronardi L, et al. Meningiomas infiltrating the superior sagittal sinus: surgical considerations of 328 cases. Neurosurg Rev 2006;29:236-241.
37. Carrabba G, Fava E, Giussani C, et al. Cortical and subcortical motor mapping in rolandic and perirolandic glioma surgery: impact on postoperative morbidity and extent of resection. J Neurosurg Sci 2007;51:45-51.
38. Gavrilovic IT, Posner JB. Brain metastases: epidemiology and pathophysiology. J Neurooncol 2005;75:5-14.
39. Ewend MG, Elbabaa S, Carey LA. Current treatment paradigms for the management of patients with brain metastases. Neurosurgery 2005;57:S66-77.
40. Gattellari M, Butow PN, Tattersall MH. Sharing decisions in cancer care. Soc Sci Med 2001;52:1865-1878.
41. Kased N, Huang K, Nakamura JL, et al. Gamma knife radiosurgery for brainstem metastases: the UCSF experience. J Neurooncol 2008;86:195-205.
42. Mathieu D, Kondziolka D, Cooper PB, et al. Gamma knife radio-surgery in the management of malignant melanoma brain metastases. Neurosurgery 2007;60:471-481.
43. Yen CP, Sheehan J, Patterson G, Steiner L. Gamma knife surgery for metastatic brainstem tumors. J Neurosurg 2006;105:213-219.
44. Nussbaum ES, Djalilian HR, Cho KH, Hall WA. Brain metastases. Histology, multiplicity, surgery, and survival. Cancer 1996; 78:1781-1788.
45. Claus EB, Bondy ML, Schildkraut JM, Wiemels JL, et al. Epidemiology of intracranial meningioma. Neurosurgery 2005;57: 1088-1095.
46. Bauchet L, Rigau V, Mathieu-Daude H, et al. French brain tumor data bank: methodology and first results on 10,000 cases. J Neurooncol 2007;84:189-199.
47. Special report of Brain Tumor Registry of Japan (1969-1990). Neurol Med Chir (Tokyo) 1999;39:59-107.
48. Wrensch M, Minn Y, Chew T, et al. MS. Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro Oncol 2002;4:278-299.
49. Barnholtz-Sloan JS, Kruchko C. Meningiomas: causes and risk factors. Neurosurg Focus 2007;23:E2.
50. Post KD, Shrivastava RK: Functioning Pituitary Tumors, in Rengachary SS, Ellenbogen RG (eds); Principles of Neurosurgery, ed 2; London; Elsevier Mosby, 2005: p. 593-607.
51. Ezzat S, Asa SL, Couldwell WT, et al. The prevalence of pituitary adenomas: a systematic review. Cancer 2004;101:613-619.
52. Hall WA, Luciano MG, Doppman JL, et al. Pituitary magnetic resonance imaging in normal human volunteers: occult adenomas in the general population. Ann Intern Med 1994;120:817-820.
53. Gillam MP, Molitch ME, Lombardi G, et al. Advances in the treatment of prolactinomas. Endocr Rev 2006;27:485-534.
54. Beckers A, Daly AF. The clinical, pathological, and genetic features of familial isolated pituitary adenomas. Eur J Endocrinol 2007;157:371-382.
55. Hemminki k, Forsti A, Ji J. Incidence and familial risks in pituitary adenoma and associated tumors. Endocr Relat Cancer 2007; 14:103-109.
56. Karhu A, Aaltonen LA. Susceptibility to pituitary neoplasia related to MEN-1, CDKN1B and AIP mutations: an update. Hum Mol Genet 2007;16 Spec No 1:R73-79.
57. Daly AF, Rixhon M, Adam C, et al. High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium. J Clin Endocrinol Metab 2006;91:4769-4775.
58. Nilsson B, Gustavasson-Kadaka E, Bengtsson BA, et al. Pituitary adenomas in Sweden between 1958 and 1991: incidence, survival, and mortality. J Clin Endocrinol Metab 2000;85:1420-1425.
59. Preston-Martin S: Epidemiology, in Berger M, Wilson C (eds); The gliomas; Philadelphia; WB Saunders Company, 1999: p. 2-9.
60. Giles GG, MF G: Epidemiology of brain tumors and factors in prognosis, in Kaye A, J ERL (eds); Brain Tumors; London; Churchill Livingstone, 2001: p. 51-66.
61. Davis FG, Freels S, Grutsch J, et al. Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973-1991. J Neurosurg 1998; 88:1-10.
62. Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005;352:987-996.
63. Mrugala MM, Batchelor TT, Plotkin SR. Peripheral and cranial nerve sheath tumors. Curr opin Neurol 2005;18:604-610.
64. Rivera-Reyes L, Toro-Sola MA. Childhood neurofibromatosis in Puerto Rico. Bol Asoc Med P R 1982;74:339-341.
65. Ferner RE. Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective. Lancet Neurol 2007;6:340-351.
66. MacCollin M, Chiocca EA, Evans DG, et al. Diagnostic criteria for schwannomatosis. Neurology 2005;64:1838-1845.